126 related articles for article (PubMed ID: 8662778)
1. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells.
Verbsky JW; Bach EA; Fang YF; Yang L; Randolph DA; Fields LE
J Biol Chem; 1996 Jun; 271(24):13976-80. PubMed ID: 8662778
[TBL] [Abstract][Full Text] [Related]
2. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells.
Gurniak CB; Berg LJ
Blood; 1996 Apr; 87(8):3151-60. PubMed ID: 8605329
[TBL] [Abstract][Full Text] [Related]
3. Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7.
Musso T; Johnston JA; Linnekin D; Varesio L; Rowe TK; O'Shea JJ; McVicar DW
J Exp Med; 1995 Apr; 181(4):1425-31. PubMed ID: 7535338
[TBL] [Abstract][Full Text] [Related]
4. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
5. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells.
Lai KS; Jin Y; Graham DK; Witthuhn BA; Ihle JN; Liu ET
J Biol Chem; 1995 Oct; 270(42):25028-36. PubMed ID: 7559633
[TBL] [Abstract][Full Text] [Related]
6. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.
Saharinen P; Silvennoinen O
J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625
[TBL] [Abstract][Full Text] [Related]
7. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation.
Liu KD; Gaffen SL; Goldsmith MA; Greene WC
Curr Biol; 1997 Nov; 7(11):817-26. PubMed ID: 9382798
[TBL] [Abstract][Full Text] [Related]
8. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
[TBL] [Abstract][Full Text] [Related]
9. JAK3: expression and mapping to chromosome 19p12-13.1.
Safford MG; Levenstein M; Tsifrina E; Amin S; Hawkins AL; Griffin CA; Civin CI; Small D
Exp Hematol; 1997 May; 25(5):374-86. PubMed ID: 9168059
[TBL] [Abstract][Full Text] [Related]
10. Characterization and analysis of the proximal Janus kinase 3 promoter.
Aringer M; Hofmann SR; Frucht DM; Chen M; Centola M; Morinobu A; Visconti R; Kastner DL; Smolen JS; O'Shea JJ
J Immunol; 2003 Jun; 170(12):6057-64. PubMed ID: 12794134
[TBL] [Abstract][Full Text] [Related]
11. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha.
Malabarba MG; Kirken RA; Rui H; Koettnitz K; Kawamura M; O'Shea JJ; Kalthoff FS; Farrar WL
J Biol Chem; 1995 Apr; 270(16):9630-7. PubMed ID: 7721895
[TBL] [Abstract][Full Text] [Related]
12. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
Rane SG; Reddy EP
Oncogene; 1994 Aug; 9(8):2415-23. PubMed ID: 7518579
[TBL] [Abstract][Full Text] [Related]
13. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
Murata T; Noguchi PD; Puri RK
J Biol Chem; 1995 Dec; 270(51):30829-36. PubMed ID: 8530527
[TBL] [Abstract][Full Text] [Related]
14. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
[TBL] [Abstract][Full Text] [Related]
15. Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferation.
Nelson BH; McIntosh BC; Rosencrans LL; Greenberg PD
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1878-83. PubMed ID: 9050873
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.
Witthuhn BA; Silvennoinen O; Miura O; Lai KS; Cwik C; Liu ET; Ihle JN
Nature; 1994 Jul; 370(6485):153-7. PubMed ID: 8022486
[TBL] [Abstract][Full Text] [Related]
17. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
[TBL] [Abstract][Full Text] [Related]
18. Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery.
Witthuhn BA; Williams MD; Kerawalla H; Uckun FM
Leuk Lymphoma; 1999 Jan; 32(3-4):289-97. PubMed ID: 10037026
[TBL] [Abstract][Full Text] [Related]
19. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.
Murata T; Husain SR; Mohri H; Puri RK
Int Immunol; 1998 Aug; 10(8):1103-10. PubMed ID: 9723696
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.
Takahashi T; Shirasawa T
FEBS Lett; 1994 Apr; 342(2):124-8. PubMed ID: 8143863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
